Posted by Michael Wonder on 22 Sep 2020
ICER posts draft scoping document on therapies for multiple myeloma
22 September 2020 - Document open to public comment until 13 October 2020.
The Institute for Clinical and Economic Review has posted a draft scoping document outlining a planned review of the comparative clinical effectiveness and value of CAR-T treatments and a monoclonal antibody drug for multiple myeloma.
